http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022054412-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97eeb4d290159e3a1ae7c408685a4f67
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197
filingDate 2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18a5cf19955e6deb26abfbf20f7d2a07
publicationDate 2022-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022054412-A1
titleOfInvention Topical formulation and methods for neuropathy relief
abstract Disclosed herein is a formulation for relief of symptoms associated with neuropathy, such as pain, burning, itching, or tingling. The formulation comprises ketamine HCL, gabapentin, piroxicam, clonidine HCL, nifedipine, and lidocaine HCL in a cream base for topical application for relief of neuropathy symptoms. Disclosed herein is a method of making a formulation for relief of symptoms associated with neuropathy, such as pain, burning, itching, or tingling, the formulation comprising ketamine HCL, gabapentin, piroxicam, clonidine HCL, nifedipine, and lidocaine HCL in a cream base suitable for topical application. Disclosed herein is a method of using a formulation for relief of symptoms associated with neuropathy, such as pain, burning, itching, or tingling, the formulation comprising ketamine HCL, gabapentin, piroxicam, clonidine HCL, nifedipine, and lidocaine HCL in a cream base for topical application to relieve symptoms of neuropathy.
priorityDate 2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7687080-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9987322-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8137711-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019105261-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096537-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7914823-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8629184-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6555573-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226404047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12374

Total number of triples: 75.